Literature DB >> 27530133

Recurrent pre-eclampsia and subsequent cardiovascular risk.

Nathalie Auger1,2, William D Fraser3, Mireille Schnitzer4, Line Leduc5, Jessica Healy-Profitós1,2, Gilles Paradis1,6.   

Abstract

OBJECTIVE: To determine the association between recurrent pre-eclampsia and long-term cardiovascular hospitalisation.
METHODS: This study identified cardiovascular hospitalisations up to 25 years after pregnancy for all women who delivered between 1989 and 2013 in Québec, Canada. Exposures included recurrent and non-recurrent pre-eclampsia in women with two deliveries or more (N=606 820), and pre-eclampsia in women with only one delivery (N=501 761). Incidence, timing and risk of cardiovascular complications were calculated using accelerated failure time models adjusted for age, pre-existing disease, socioeconomic deprivation and period. Outcomes included a range of cardiovascular hospitalisations and procedures.
RESULTS: Women with recurrent pre-eclampsia had higher incidence of cardiovascular hospitalisation (281.4 per 1000) than women with non-recurrent (167.7 per 1000) or no pre-eclampsia (72.6 per 1000). Mean time to cardiovascular hospitalisation was 10.5 years for recurrent, 11.6 years for non-recurrent and 12.7 years for no pre-eclampsia, a difference of 17.3% for recurrent and 8.7% for non-recurrent relative to no pre-eclampsia. Compared with no pre-eclampsia, recurrent pre-eclampsia was associated with 2 times the risk of heart disease (95% CI 1.69 to 2.29) and 3 times the risk of cerebrovascular disease (95% CI 2.25 to 4.05). Pre-eclampsia in women with one delivery was associated with 3 times greater risk of cardiovascular hospitalisation compared with no pre-eclampsia in women with two deliveries or more (95% CI 2.96 to 3.25).
CONCLUSIONS: Recurrent pre-eclampsia is associated with higher risk of future cardiovascular hospitalisation compared with no pre-eclampsia, and significantly shorter time to first cardiovascular event. Cardiovascular screening should be performed earlier for women with recurrent pre-eclampsia. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Mesh:

Year:  2016        PMID: 27530133     DOI: 10.1136/heartjnl-2016-309671

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  22 in total

1.  Heart Failure in Women With Hypertensive Disorders of Pregnancy: Insights From the Cardiovascular Disease in Norway Project.

Authors:  Michael C Honigberg; Hilde Kristin Refvik Riise; Anne Kjersti Daltveit; Grethe S Tell; Gerhard Sulo; Jannicke Igland; Kari Klungsøyr; Nandita S Scott; Malissa J Wood; Pradeep Natarajan; Janet W Rich-Edwards
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

Review 2.  Hypertensive Disorders of Pregnancy and Cardiovascular Diseases: Current Knowledge and Future Directions.

Authors:  Thais Coutinho; Olabimpe Lamai; Kara Nerenberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-06-19

Review 3.  Adverse pregnancy outcomes and future maternal cardiovascular disease.

Authors:  Alisse Hauspurg; Wendy Ying; Carl A Hubel; Erin D Michos; Pamela Ouyang
Journal:  Clin Cardiol       Date:  2018-02-15       Impact factor: 2.882

Review 4.  Preeclampsia Emerging as a Risk Factor of Cardiovascular Disease in Women.

Authors:  Emmanouil Chourdakis; Nikos Oikonomou; Sotirios Fouzas; George Hahalis; Ageliki A Karatza
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-03-03

5.  Long-term effects of preeclampsia on maternal cardiovascular health and postpartum utilization of primary care: an observational claims data study.

Authors:  Kathrin Haßdenteufel; Mitho Müller; Raphael Gutsfeld; Maren Goetz; Armin Bauer; Markus Wallwiener; Sara Y Brucker; Stefanie Joos; Miriam Giovanna Colombo; Sabine Hawighorst-Knapstein; Ariane Chaudhuri; Gudula Kirtschig; Frauke Saalmann; Stephanie Wallwiener
Journal:  Arch Gynecol Obstet       Date:  2022-04-28       Impact factor: 2.344

6.  Development and internal validation of a model to predict type 2 diabetic complications after gestational diabetes.

Authors:  Ugochinyere Vivian Ukah; Robert W Platt; Nathalie Auger; Kaberi Dasgupta; Natalie Dayan
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

7.  Lactation Patterns in Women with Hypertensive Disorders of Pregnancy: An Analysis of Illinois 2012-2015 Pregnancy Risk Assessment Monitoring System (PRAMS) Data.

Authors:  Adriane Burgess; Emily Eichelman; Brittney Rhodes
Journal:  Matern Child Health J       Date:  2020-11-16

8.  Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy.

Authors:  Lauren H Theilen; Huong Meeks; Alison Fraser; M Sean Esplin; Ken R Smith; Michael W Varner
Journal:  Am J Obstet Gynecol       Date:  2018-04-07       Impact factor: 8.661

9.  Early predictors of Guillain-Barré syndrome in the life course of women.

Authors:  Nathalie Auger; Caroline Quach; Jessica Healy-Profitós; Trish Dinh; Michaël Chassé
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

Review 10.  Blood Pressure Variability in Pregnancy: an Opportunity to Develop Improved Prognostic and Risk Assessment Tools.

Authors:  Jane V Vermunt; Stephen H Kennedy; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2020-02-01       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.